[1] Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet.doi.org/10.1016/S0140-6736(16)31919-5
[2] Wang C, Yuan Y, Zheng M, et al. Association of Age of Onset of Hypertension WithCardiovascular Diseases and Mortality. J Am Coll Cardiol.2020.doi.org/10.1016/j.jacc.2020.04.038
[3] Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020 Jun;75(6):1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. Epub 2020 May 6. PMID: 32370572.
[4] Wyss F, Coca A, Lopez-Jaramillo P, Ponte-Negretti C; Task Force for the management of Arterial Hypertension of the Interamerican Society of Cardiology (IASC); Reviewers from European Society of Hypertension (ESH), Latin-American Society of Hypertension (LASH), Spanish Society of Cardiology (SSC). Position statement of the Interamerican Society of Cardiology (IASC) on the current guidelines for the prevention, diagnosis and treatment of arterial hypertension 2017-2020. Int J Cardiol Hypertens. 2020 Jul 15;6:100041. doi: 10.1016/j.ijchy.2020.100041. PMID: 33447767; PMCID: PMC7803017.
[5] Luo D, Cheng Y, Zhang H, Ba M, Chen P, Li H, Chen K, Sha W, Zhang C, Chen H. Association between high blood pressure and long term cardiovascular events in young adults: systematic review and meta-analysis. BMJ. 2020 Sep 9;370:m3222. doi: 10.1136/bmj.m3222. PMID: 32907799; PMCID: PMC7478061.
[6] Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.JAMA. 2003; 289:2560–2572.
[7] Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, et al.. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo: The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.N Engl J Med. 1993; 328:914–921.
[8] Gong Y, McDonough CW, Wang Z, Hou W, Cooper-DeHoff RM, Langaee TY, Beitelshees AL, Chapman AB, Gums JG, Bailey KR, Boerwinkle E, Turner ST, Johnson JA. Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study. Circ Cardiovasc Genet. 2012 Dec;5(6):686-91. doi: 10.1161/CIRCGENETICS.112.964080. Epub 2012 Oct 19. PMID: 23087401; PMCID: PMC3529147.
[9] Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2012 update: a report from the American Heart Association.Circulation. 2012; 125:e2–e220.
[10] Dickerson JE, Hingorani AD, Ashby MJ, Palmer CR, Brown MJ. Optimisation of antihypertensive treatment by crossover rotation of four major classes.Lancet. 1999; 353:2008–2013.
[11] Gong Y, McDonough CW, Wang Z, Hou W, Cooper‐DeHoff RM, Langaee TY, Beitelshees AL, Chapman AB, Gums JG, Bailey KR, Boerwinkle E, Turner ST, Johnson JA. Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study. Circ Cardiovasc Genet. 2012; 5:686–691.
[12] Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, Sim X, et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet. 2011 Jun;43(6):531–8.
[13] Lu X, Wang L, Lin X, Huang J, Charles Gu C, He M, et al. Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. Hum Mol Genet. 2015 Feb;24(3):865–74.
[14] Wang Jie, Xingjiang Xiong, Evidence-based chinese medicine for hypertension, Evidence-based complementary and alternative medicine: eCAM. 2013 (2013), 978398.
[15] Xingjiang Xiong, Xiaochen Yang, Wei Liu, Fuyong Chu, Pengqian Wang, Jie Wang, Trends in the treatment of hypertension from the perspective of traditional Chinese medicine, Evidence-based complementary alternative medicine: eCAM. 2013, 275279.
[16] Li-fang Luo, Wei-hua Wu, Ying-jun Zhou, Jin Yan, Guo-ping Yang, Dongsheng Ouyang, Antihypertensive effect of Eucommia ulmoides Oliv, extracts in spontaneously hypertensive rats, J. Ethnopharmacol. 129 (2) (2010) 238–243.
[17] Yansheng Yao, Yanbing Wang, Yibo Zhang, Chang Liu, Klotho ameliorates oxidized low-density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways, Lipids Health Dis. 16 (2017) 77.
[18] Kai He, Xuegang Li, Xin Chen, Xiaoli Ye, Jing Huang, Yanan Jin, Panpan Li, Yafei Deng, Qing Jin, Qing Shi, Hejing Shu, Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice, J. Ethnopharmacol. 137 (3) (2011) 1135–1142.
[19] Xinxin Dai, Shulan Su, Hongdie Cai, Dandan Wei, Hui Yan, Tianyao Zheng, Zhenhua Zhu, Er-Xin Shang, Sheng Guo, Dawei Qian, Jin-Ao Duan, Protective effects of total glycoside from Rehmannia glutinosa leaves on diabetic nephropathy rats via regulating the metabolic profiling and modulating the TGF-β1 and wnt/β-Catenin signaling pathway, Front. Pharmacol. 9 (2018) 1012.
[20] Lei Ren, Yapei Xu, Guijun Qin, Cong Liu, Shoujun Wang, Effects of water extracts of Rehmannia glutinosa on antioxidant system of Nrf2 in paraquat-induced insulin resistance diabetic rat model, Exp. Ther. Med. 14 (6) (2017) 5847–5850.
[21] X. Duan, W. Wang, X. Liu, H. Yan, R. Dai, Q. Lin, Neuroprotective effect of ethyl acetate extract from gastrodia elata against transient focal cerebral ischemia in rats induced by middle cerebral artery occlusion, J. Tradit. Chin. Med. 35 (6) (2015) 671–678.
[22] Min Chul Kho, Yun Jung Lee, Jeong Dan Cha, Kyung Min Choi, Dae Gill Kang, Sub Lee Ho, Gastrodia elata ameliorates high-fructose diet-induced lipid metabolism and endothelial dysfunction, Evidence-based complementary alternative medicine: eCAM. 2014 (2014), 101624.
[23] Yuan Liu, Jialiang Gao, Min Peng, Hongyan Meng, Hongbo Ma, Pingping Cai, Yuan Xu, Qiong Zhao, Guomin Si, A review on central nervous system effects of Gastrodin, Front. Pharmacol. 2 (9) (2018) 24.
[24] Hye-Lin Kim, Yong-Deok Jeon, Jinbong Park, Hong-Kun Rim, Mi-Young Jeong, Hara Lim, Seong-Gyu Ko, Hyeung-Jin Jang, Byung-Cheol Lee, Kyung-Tae Lee, Kang-Min Lee, Hyejung Lee, Sung-Hoon Kim, Su-Jin Kim, Seung-Heon Hong, JaeYoung Um, Corni fructus containing formulation attenuates weight gain in mice with diet-induced obesity and regulates adipogenesis through AMPK, Evid. Complement. Alternat. Med. 2013 (2013), 423741.
[25] Dongying Wang, Chenxi Li, Wenchang Fan, Tao Yi, Anchi Wei, Yuxiang Ma, Hypoglycemic and hypolipidemic effects of a polysaccharide from Fructus Corni in streptozotocin-induced diabetic rats, Int. J. Biol. Macromol. 133 (2019) 420–427.
[26] Chien-Chih Chen, Chia-Yun Hsu, Chin-Ying Chen, Hui-Kang Liu, Fructus Corni suppresses hepatic gluconeogenesis related gene transcription, enhances glucose responsiveness of pancreatic beta-cells, and prevents toxin induced beta-cell death, J. Ethnopharmacol. 117 (3) (2008) 483–490.
[27] Dawei Gao, Qingwang Li, Zhengrong Gao, Lixin Wang, Antidiabetic effects of Corni Fructus extract in streptozotocin-induced diabetic rats, Yonsei Med. J. 53 (4) (2012) 691–700.
[28] Chan Hum Park, Jeong Sook Noh, Jong Cheol Park, Takako Yokozawa, Beneficial effect of 7-O-Galloyl-D-sedoheptulose, a polyphenol isolated from corni fructus, against diabetes-induced alterations in kidney and adipose tissue of type 2 diabetic db/db mice, Evidence-based complementary alternative medicine: eCAM. 2013 (2013), 736856.
[29] Thi Ha Do, Trinh Nam Trung, Tran Thi Hien, Trong Tuan Dao, Namhui Yim, Tran Minh Ngoc, Oh Won Keun, Kih Wan Bae, Selected compounds derived from Moutan Cortex stimulated glucose uptake and glycogen synthesis via AMPK activation in human HepG2 cells, J. Ethnopharmacol. 131 (2) (2010) 417–424.
[30] Juan Chen, Xue-Feng Hou, Gang Wang, Qing-Xiang Zhong, Ying Liu, Hui-Hui Qiu, Nan Yang, Jun-Fei Gu, Chun-Fei Wang, Li Zhang, Jie Song, Lu-Qi Huang, XiaoBin Jia, Ming-Hua Zhang, Liang Feng, Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses, J. Ethnopharmacol. 193 (2016) 433–444.
[31] Hong Dan, Juan Wu, Min Peng, Xuefeng Hu, Chengwu Song, Zhiwen Zhou, Shanggong Yu, Nianbai Fang, Hypolipidemic effects of Alismatis rhizome on lipid profile in mice fed high-fat diet, Saudi Med. J. 32 (7) (2011) 701–707.
[32] X. Zhou, Q. Ren, B. Wang, G. Fang, Y. Ling, X. Li, Alisol a 24-Acetate isolated from the alismatis rhizoma improves hepatic lipid deposition in hyperlipidemic mice by ABCA1/ABCG1 pathway, J Nanosci Nanotechno. 19 (9) (2019) 5496–5502.
[33] Chiakang Ho, Ya Gao, Danning Zheng, Yanjun Liu, Shengzhou Shan, Bin Fang, Yixuan Zhao, Dingzhong Song, Yifan Zhang, Qingfeng Li, Alisol A attenuates highfat-diet-induced obesity and metabolic disorders via the AMPK/ACC/SREBP-1c pathway, J. Cell. Mol. Med. 23 (8) (2019) 5108–5118.
[34] Y.B. Chen, Y.H. Dong, Clinical effect and pharmacological analysis of panax notoginseng saponins in the treatment of hyperlipidmia, China Med Pharm. 6 (139) (2006) 51–53.
[35] D.U. Xue-Jun, Yan Lei, Jing Yang, Effects of Radix ginseng and Radix notoginseng formula on expressions of vascular endothelial growth factor receptor-2 and hypoxia-inducible factor-1alpha in ischemic myocardium of rats with acute myocardial infarction, Zhong Xi Yi Jie He Xue Bao 8 (6) (2010) 548-553.
[36] Long-Tao Liu, Guang-Juan Zheng, Wen-Gao Zhang, Gang Guo, Min Wu, Clinical study on treatment of carotid atherosclerosis with extraction of polygoni cuspidati rhizoma et Radix and crataegi fructus: a randomized controlled trial, Zhongguo Zhong Yao Za Zhi 39 (6) (2014) 1115-1119.
[37] E. Dalli, E. Colomer, M.C. Tormos, J. Cosín-Sales, J. Milara, E. Esteban, G. Saez, ´ Crataegus laevigata decreases neutrophil elastase and has hypolipidemic effect: a randomized, double-blind, placebo- controlled trial, Phytomedicine 18 (2011) 769–775.
[38] X.C. Yang, X.J. Xiong, J. Wang, Clinical observation of 108 cases of primary hypertension treated with bu shen jiang ya therapy, World J. Integr. Traditional Western Med. 10 (2014) 1083–1087.
[39] Wang Jie, Xingjiang Xiong, Current situation and perspectives of clinical study in integrative medicine in china, Evidence-based complementary alternative medicine: eCAM. 2012 (2012), 268542.
[40] Jie Wang, Xingjiang Xiong, Wei Liu, Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients, Evidence-based complementary and alternative medicine, eCAM 2014 (2014), 418206.
[41] W. Liu, J. Wang, X.J. Xiong, X.C. Yang, Experimental study of bu shen jiang ya decoction on acute toxicology, Beijing J Tridit Chin Med. 32 (2013) 647–649.
[42] Xingjiang Xiong, Xiaochen Yang, Lian Duan, Wei Liu, Yun Zhang, Yongmei Liu, Pengqian Wang, Shengjie Li, Xiaoke Li, Traditional Chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal-regulated kinases signaling pathway in spontaneously hypertensive rats, Sci. Rep. 7 (2017) 42965.
[43] Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63(8):e1–e37.
[44] Boutron I, Altman DG, Moher D, et al. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40–47.
[45] Chan A W, Tetzlaff J M, Gøtzsche P C, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials[J]. BMJ. 2013;346:e7586.
[46] Liu J. Highlights of the 2018 Chinese hypertension guidelines. Clin Hypertens. 2020 May 1;26:8. doi: 10.1186/s40885-020-00141-3. PMID: 32377372; PMCID: PMC7193361.
[47] World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79(4):373–4.
[48] Switula D. Principles of good clinical practice (GCP) in clinical research. Sci Eng Ethics. 2000;6(1):71–77.
[49] Zheng XY. Guiding Principles for Clinical Research of New Chinese Medicines. China Medical Science and Technology Press. 2002; 4:73–77.
[50] Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.
[51] Insana SP, Hall M, Buysse DJ, Germain A. Validation of the Pittsburgh Sleep Quality Index Addendum for posttraumatic stress disorder (PSQI-A) in U.S. male military veterans. J Trauma Stress. 2013;26(2):192–200.
[52] Wan X, Zh L, Liu JP. Estimation of sample size in clinical studies: (1) clinical trials. Journal of Traditional Chinese Medicine 2017; 48:504–7.
[53] Ventura HO, Taler SJ, Strobeck JE. Hypertension as a hemodynamic disease: the role of impedance cardiography in diagnostic, prognostic, and therapeutic decision making. Am J Hypertens. 2005;18(2 Pt 2):26S–43S.
[54] Liu W, Li Y, Xiong X, Chen Y, Qiao L, Wang J, Su X, Chu F, Liu H. Traditional Chinese medicine protects against hypertensive kidney injury in Dahl salt-sensitive rats by targeting transforming growth factor-β signaling pathway. Biomed Pharmacother. 2020 Nov;131:110746. doi: 10.1016/j.biopha.2020.110746. Epub 2020 Sep 17. PMID: 33152915.
[55] Yang Xiao-chen, Zhang Yun, Liu Yongmei, Wang Jie. Explore mechanism of Bushen Jiangya Decoction for hypertension based on network pharmacology. Chinses Journal of Integrative Medicine on Cardio-cerebrovascular disease. 2021, 19 (2): 197-205.